Skip to main content

Michael Cavanaugh Joins Laureat Pharma from GE Healthcare; George Bers New Executive VP of Genospectra; Brent Keller to Head New Kreatech US Office; And Others

Michael Cavanaugh has joined Laureate Pharma as vice president of sales, marketing, and business development, the Princeton, NJ-based company said today. He used to be vice president of marketing and sales support for North Americawith Amersham/GE Healthcare, where he was responsible for products that included instruments and reagents for genomics, proteomics, screening, cellular analysis, and preclinical imaging. Prior to that, he was senior director of business development Europeat Gene Logic. Cavanaugh holds a master's degree in clinical microbiology with a minor in biochemistry from Hahnemann Medical College in Philadelphiaand a BS in biology with a minor in chemistry from Fairfield University, Conn.

George Bers has become executive vice president of commercial operations at Genospectra, a new position, the Fremont, Calif.-based company said today. In the past, he held various senior executive management positions at NuGen, Beckman Coulter, Nanogen, and Bio-Rad Laboratories. Bers has an MS in biochemistry from GeorgetownUniversity and a BA from DukeUniversity.

Brent Keller has been appointed as general manager of Kreatech Biotechnology USA, Kreatech's new San Diego-based USoffice, the Amsterdam, Netherlands-based company said yesterday. He is currently Kreatech's vice president for commercial operations, working for the company part-time. He holds an MBA in strategic planning and marketing from PepperdineUniversityand a BS in biology, along with graduate training in viral immunology, from Rensselaer Polytechnic Institute.

Michael Schubert has been promoted to executive vice president and Ian Sanders to vice president for European life science sales of Bruker Daltonics, the company said last week.


Schubert retains his previous responsibilities for Bruker Daltonics' global R&D management, and remains managing director of Bruker Daltonik in Bremenand Leipzig, Germany. In addition, he now also assumes responsibility for the company's life-science mass spectrometry business in the Americas. Schubert holds a doctorate in physics from the Universityof Hamburg, Germany.


Sanders was previously assistant vice president. He also continues in his role as managing director of Bruker Daltonik. Schubert holds a PhD in drug discovery technology from the Universityof Bath, UK.

Mathew Hahn has been promoted to chief science and technology officer of Accelrys, the company said last week. Hahn, a co-founder of SciTegic, which Accelrys acquired in 2004, will remain general manager of the SciTegic subsidiary. Han holds a PhD from the Universityof Santa Cruz.

Jean-Paul Mangeolle has been promoted to president of the bioprocess division of Millipore, the company said yesterday. He used to be vice president of worldwide field operations for the same division. Mangeolle holds an MS in chemical engineering from the Universityof Montpellier in Franceand a BS BA in environmental engineering from the University of Chambery, France.

Promoted? Changing jobs? GenomeWeb News wants to know. E-mail us at [email protected] to announce your move in PEOPLE, a weekly roundup of personnel changes in the genomics industry.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.